Q4 2025 Management View Mahkam Zanganeh, Co-CEO, President & Director, highlighted ongoing accomplishments and "the growing positive data sets and support around ivonescimab, a PD-1 VEGF bispecific or ...
BRCA1-Associated Protein 1 and Enhancer of Zeste Homolog 2: Pathway Interaction and Therapeutic Intervention in Breast Cancer, Mesothelioma, and Lymphoma Early-phase clinical trials (EPCTs) have been ...
Summit Therapeutics Inc. (NASDAQ: SMMT) ("Summit," "we," or the "Company") today reports its financial results and provides an update on clinical and operational progress for the fourth quarter and ...
Objectives Anti-neutrophil cytoplasmic antibody-associated vasculitis (AAV) is a systemic autoimmune disease where infections ...
Molecular diagnostics clarify hand dermatoses and guide targeted therapy in new research. Learn how gene-expression testing ...
Children with pediatric obstructive sleep apnea had higher influenza and COVID-19 diagnoses over five years in a large matched cohort.
Germany: A real-world prospective cohort study published in RMD Open: Rheumatic & Musculoskeletal Diseases suggests that ...
As you recall, we initially included PFS as a primary endpoint in this study opened the readout of HARMONY-2, comparing ivanisimab to pembro, in PD-L positive frontline lung cancer patients, which ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results